Neurobiological aspects of psychosis and gender

Psychiatria Danubina

Volumn 21, Issue SUPPL. 1, 2009, Pages 128-131

  Pregelj, Peter ^a  

^a UNIVERSITY PSYCHIATRIC HOSPITAL   (Slovenia)

Author keywords

Differences; Epigenetic factors; Estrogen; Gender; Psychosis; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DOPAMINE; ESTROGEN; GLUTAMIC ACID; NEUROLEPTIC AGENT; NORADRENALIN; SEROTONIN;

CONFERENCE PAPER; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GABAERGIC SYSTEM; GENE EXPRESSION; HUMAN; HYPERPROLACTINEMIA; MENSTRUAL CYCLE; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; PATHOGENESIS; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN; DNA METHYLATION; EPIGENESIS, GENETIC; ESTROGENS; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEX FACTORS; SOCIAL ENVIRONMENT;

EID: 70350316137     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT & Thiagalingam S: Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006; 15:3132-3145 (Pubitemid 44607800)
2. Abdolmaleky HM, Smith CL, Zhou JR & Thiagalingam S: Epigenetic alterations of the dopaminergic system in major psychiatric disorders. Methods Mol Biol 2008; 448:187-212.
3. Benes FM & Berretta S: GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25:1-27.
4. Bergemann N, Mundt C, Parzer P, Jannakos I, Nagl I, Salbach B, Klinga K, Runnebaum B & Resch F: Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophr Res 2005; 73:357-366 (Pubitemid 40093900)
5. Bergemann N, Mundt C, Parzer P, Jannakos I, Nagl I, Salbach B, Klinga K, Runnebaum B & Resch F: Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophr Res 2005; 73:357-366 (Pubitemid 40093900)
6. Boulware MI & Mermelstein PG: The influence of estradiol on nervous system function. Drug News Perspect 2005; 18:631-637
7. Boulware MI & Mermelstein PG: The influence of estradiol on nervous system function. Drug News Perspect 2005; 18:631-637
8. Canuso CM & Pandina G: Gender and schizophrenia. Psychopharmacol Bull 2007; 40:178-190
9. Connor CM & Akbarian S: DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 2008; 3:55-58
10. Cyr M, Colon F, Morissette M & Di PT: Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J Psychiatry Neurosci 2002; 27:12-27. (Pubitemid 34478366)
11. Garcia-Segura LM, Azcoitia I & DonCarlos LL: Neuroprotection by estradiol. Prog Neurobiol 2001; 63:29-60.
12. Huang HS & Akbarian S: GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS ONE. 2007; 2:e809.
13. Huber TJ, Borsutzky M, Schneider U & Emrich HM: Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 2004; 109:269-274 (Pubitemid 38406708)
14. Huber TJ, Borsutzky M, Schneider U & Emrich HM: Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 2004; 109:269-274 (Pubitemid 38406708)
15. Huber TJ, Borsutzky M, Schneider U & Emrich HM: Psychotic disorders and gonadal junction: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 2004; 109:269-274 (Pubitemid 38406708)
16. Huber TJ, Rollnik J, Wilhelms J, von zur MA, Emrich HM & Schneider U: Estradiol levels in psychotic disorders. Psychoneuroendocrinology 2001; 26:27-35.
17. Huber TJ, Rollnik J, Wilhelms J, von zur MA, Emrich HM & Schneider U: Estradiol levels in psychotic disorders. Psychoneuroendocrinology 2001; 26:27-35.
18. Huber TJ, Tettenborn C, Leifke E & Emrich HM: Sex hormones in psychotic men. Psychoneuroendocrinology 2005; 30:111-114
19. Jones PB & Buckley PF: Schizophrenia. Elsevier Spain 2006.
20. Leung A & Chue P: Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000; 401:3-38. (Pubitemid 30412890)
21. McEwen B: Estrogen actions throughout the brain. Recent Prog Horm Res 2002; 57:357-384
22. McEwen B: Estrogen actions throughout the brain. Recent Prog Horm Res 2002; 57:357-384
23. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC & Petronis A: Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008; 82:696-711. (Pubitemid 351726115)
24. Olsen L, Hansen T, Jakobsen KD, Djurovic S, Melle I, Agartz I, Hall H, Ullum H, Timm S, Wang AG, Jönsson EG, Andreassen OA & Werge T: The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Med Genet 2008; 9-39. (Pubitemid 351737013)
25. Riecher-Rossler A, Hafner H, Stumbaum M, Maurer K & Schmidt R: Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994; 20:203-214.
26. Salokangas RK: Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis. Schizophr Res 1995; 16:7-16.
27. Seeman MV & Lang M: The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990; 16:185-194 (Pubitemid 20205356)
28. Seeman MV: Gender differences in schizophrenia. Can J Psychiatry 1982; 27(2):107-112